Skip navigation
Faqing Huang

Dr. Faqing Huang



Dr. Huang received PhD in Chemistry from Duke University in 1994. After NIH fellowship-supported postdoctoral training at University of Colorado Boulder, he joined Department of Chemistry and Biochemistry at University of Southern Mississippi in 1998. His lab conduct research in interdisciplinary areas, including catalytic RNA related to the Origin and Early Evolution of Life, bioorganic chemistry, mRNA vaccine, and targeted cancer therapeutics. He has received research grants from NASA, NIH and NSF.

Google Scholar

  • PHD - Duke University (1994)
  • MS - Qinghai Institute of Salt Lake (1987)

CHE 420-Principles of Biochemistry
CHE 520-Principles of Biochemistry
CHE 421- Biochemistry I
CHE 422- Biochemistry II
CHE 424- Biochemistry III
CHE 729-Current Topics in Biochemistry
CHE 822- Nucleic Acids and Protein synthesis

  • Topological deep learning based deep mutational scanning, Comput Biol Med, 2023, 10.1016/j.compbiomed.2023.107258
  • Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy, Stem Cell Reports, 2023, 10.1016/j.stemcr.2023.08.005
  • An effective live-attenuated Zika vaccine candidate with a modified 5' untranslated region, NPJ Vaccines, 2023, 10.1038/s41541-023-00650-w
  • Dicer and PKR as Novel Regulators of Embryonic Stem Cell Fate and Antiviral Innate Immunity, J Immunol, 2022, 10.4049/jimmunol.2200042
  • Perspectives on SARS-CoV-2 Main Protease Inhibitors, J Med Chem, 2021, 10.1021/acs.jmedchem.1c00409
  • Dicer represses the interferon response and the double-stranded RNA-activated protein kinase pathway in mouse embryonic stem cells, Journal of Biological Chemistry, 2021,
  • Single Protein Encapsulated Doxorubicin as an Efficacious Anticancer Therapeutic, Advanced Therapeutics, 2020, 10.1002/adtp.202000135
  • Cloning, expression and purification of the low-complexity region of RanBP9 protein., Protein expression and purification, 2020, 10.1016/j.pep.2020.105630
  • Selective Protection of Secondary Alcohols by Using Formic Acid as a Mild and Efficient Deprotection Reagent for Primary tert-Butyldimethylsilyl Ethers, Synlett, 2019, 10.1055/s-0037-1611757
  • Efficient one-pot enzymatic synthesis of dephospho coenzyme A, Bioorganic Chemistry, 2018, 10.1016/j.bioorg.2017.10.012
  • Chinese (Native or Bilingual)
  • English (Full Professional)

Edit profile

Contact Me

Johnson Science Tower (JST) 606 map




Areas of Expertise

Biochemistry, RNA Chemistry, Bioorganic Chemistry, mRNA Vaccine, Targeted Cancer Therapeutics